Networking Event
Science and Networking
iPSC Assay Development and Screening - a Synergistic Story
Co-organized by Axxam, Fujifilm Cellular Dynamics and Hamamatsu Photonics:
Scientific seminar and networking
Join us for a scientific seminar focused on induced Pluripotent Stem Cells.
Hamamatsu, Fujifilm Cellular Dynamics Inc. (FCDI), and Axxam S.p.A. are pleased to present a seminar showcasing iPSC integration into key components of clinically translatable early drug discovery.
Successfully translating early drug discovery efforts to the clinic requires,
- Access to patient-based and disease-relevant material and models,
- High-throughput functional screening
- An ability to interrogate and integrate across model systems and modalities to generate actionable clinically relevant data.
This seminar will showcase advancements and case-studies on these topics with an emphasis on cardiovascular and neurodegeneration discovery efforts.
Attendees will enjoy a light lunch and refreshments and have an excellent opportunity for networking with colleagues, peers, and subject-matter experts as they learn about the intersection of high-throughput functional screening, clinically relevant disease models, and successful integration into drug discovery campaigns.
Agenda
13.00-13.30 WELCOME AND REFRESHMENT
13.30-13.45 High throughput screening of iPSC using the Hamamatsu FDSSµcell
(Diana Kovalauskaite. HAMAMATSU)
13.45-14.30 iPSC-based models for drug discovery; 2D, 3D, and complex models with immune
compartments across cardiac, hepatic, and neural therapeutic areas
(Blake Anson. FCDI)
- Developing patient-based and disease-linked human models.
- Incorporating iPSC models across 2D, 3D, and complex-culture formats.
- Specific case-studies in cardiac safety, neurodegeneration, and incorporating immune-based cells (macrophage and microglia).
14.30-14.50 COFFEE BREAK
14.50-15.40 iPSC-based assays for Drug Discovery: a comprehensive screening platform
(Atf Nagbou and Silvia Cainarca. Axxam)
- General capabilities with a focus on:
- Miniaturization and adaptation to automation
- Developing iPSC-based assays for drug screening, using different type o cells, including neurons and cardiomyocytes
- Setting up of relevant disease models (PD, AD, ALS)
15.40-16.00 NETWORKING AND COCKTAIL HOUR